Archives

by in
Entry Author Date Location
Shire Pays Over $260M Upfront in IPO Detour for San Diego’s Lumena 05/12/14 National
Austin’s Lumos Pharma Gets $14M for Creatine Disorder Therapy 02/07/14 Texas
San Diego Life Sciences Roundup: Ignyta, Conatus, Liver Prize & More 12/06/13 San Diego
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
Fighting a Global War on Rare Diseases 03/20/13 New York
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Synageva BioPharma Announces $80 Million Stock Offering 01/03/13 Boston
BioMarin Delays Profit to Pursue New Products 01/03/13 San Francisco
NPS Wins First FDA Approval, for Short Bowel Syndrome Drug 12/21/12 New York
Pfizer, Cystic Fibrosis Foundation in $58 Million Pact 11/19/12 New York
East Coast Life Sciences Roundup: Pfizer, Rhythm, NPS, More 10/26/12 Boston
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More 10/19/12 New York
FDA Staff Issues Positive Report for Aegerion’s Lomatapide 10/15/12 Boston
Biotech Racking Up Successes Against Ultra-Orphan Diseases 10/15/12 New York
AesRx Navigates “Valley of Death” to Get Sickle Cell Drug Into Trials 12/14/11 Boston
Repligen Seeks Approval for Imaging Product While Pursuing Rare-Disease Drugs and Manufacturing Platform 09/01/11 Boston
Shire Wins Approval for Rare-Disease Drug Developed At Boston-Based Unit 08/25/11 Boston
Amira Drug Gets Orphan Status 04/20/11 San Diego
NPS Earns Seven-Figure Milestone Payment 03/28/11 New York
Top Five Biotech Surprises & Innovations of 2010, and Five Trends to Watch for in 2011 12/30/10 San Francisco
Page 1 of 1